| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $291.6M | +4.5% |
| R&D Expense | $48.9M | +7.4% |
| SG&A Expense | $47.2M | +3.1% |
| Operating Income | $21.3M | +32.9% |
| Pre-tax Income | $24.8M | +34.0% |
| Income Tax | $4.8M | +45.4% |
| Net Income | $20.0M | +31.5% |
| EPS (Basic) | $0.66 | +32.0% |
| EPS (Diluted) | $0.66 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $59.5M | +47.4% |
| Accounts Receivable | $30.2M | -12.1% |
| Current Assets | $153.1M | +17.6% |
| Total Assets | $510.8M | +2.2% |
| Current Liabilities | $115.7M | -2.3% |
| Stockholders' Equity | $359.4M | +5.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $57.7M | -9.9% |
| Capital Expenditures | $1.4M | -36.3% |
| Investing Cash Flow | -$34.0M | +40.0% |
| Financing Cash Flow | -$4.5M | +65.4% |
| Free Cash Flow | $56.3M | -8.9% |
| +32.0% |